

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 2mg | 360 pills | £0.32 | £136.79 £116.27 Best Price Popular | |
| 2mg | 270 pills | £0.37 | £117.06 £99.50 | |
| 2mg | 180 pills | £0.46 | £97.33 £82.73 | |
| 2mg | 120 pills | £0.53 | £73.65 £62.60 | |
| 2mg | 90 pills | £0.59 | £63.13 £53.66 | |
| 2mg | 60 pills | £0.63 | £44.71 £38.00 | |
| 2mg | 30 pills | £0.66 | £23.66 £20.11 |
This information provides general guidance on arret (Loperamide) and should not replace professional medical advice. Seek advice from a pharmacist or doctor for personal circumstances.
arret is the brand name used in the United Kingdom for the active ingredient loperamide hydrochloride. Loperamide is classified as an anti-diarrhoeal medicine that acts on the gut rather than the central nervous system. The medication is intended to reduce the frequency of stools and the liquidity of diarrhoeal stools. Availability and access may vary, and a prescription may be required depending on local rules and product presentation.
The basic purpose of arret is to provide symptom relief during episodes of diarrhoea. It is designed for short‑term use to help restore normal stool consistency and reduce urgency. The product is for adults and may be used in children only where indicated on the product label and under supervision of a healthcare professional. Always follow the package directions and consult a pharmacist if there is any doubt.
Arret works by acting on receptors in the gut to slow intestinal movement. By slowing the movement of contents through the bowel, more water is absorbed, resulting in firmer stools. The drug has limited passage into the brain, which helps avoid many central nervous system effects associated with other opioid medicines.
It is important to note that arret does not treat the underlying cause of diarrhoea. If fever, blood in the stool, dehydration, or diarrhoea lasting for several days occurs, medical advice should be sought. Check the official leaflet and seek professional guidance for any specific questions about eligibility for use.
Arret is used to relieve symptoms of acute non‑specific diarrhoea in adults and for certain labelled pediatric indications where stated on the product packaging. It may reduce the frequency of loose stools and the sensation of urgency. It is not a treatment for dehydration, an infection with fever, or diarrhoea due to a severe illness without clinical evaluation.
In cases of travel‑associated diarrhoea, arret may be used to alleviate symptoms as part of supportive care, under the advice of a clinician. It should not be used to mask more serious illness, such as persistent fever or severe abdominal pain. If the diarrhoea is accompanied by blood in the stool or dehydration, medical assessment is advised.
Chronic diarrhoea related to specific conditions may be managed with arret under medical supervision. The medication is not a cure for the underlying disease and may be used to control symptoms when appropriate. Individuals with known conditions affecting the gut should consult a healthcare professional before starting therapy.
Clinical guidance emphasises staying hydrated and recognising when diarrhoea requires medical attention. If symptoms persist beyond a short course, or if there are signs of dehydration, weakness, or confusion, professional advice should be sought promptly. The product label provides indications and exclusions that should be adhered to.
Loperamide acts on the enteric nervous system in the wall of the bowel by binding to mu‑opioid receptors. This action decreases peristaltic activity, meaning the intestinal contents move more slowly. As a result, water and electrolytes have more time to be absorbed, producing firmer stools and reducing stool frequency.
The medication has a predominantly peripheral mechanism of action, with minimal entry into the central nervous system. This results in a lower risk of typical opioid‑related side effects such as sedation or dependence in standard use. The intended effect is symptomatic relief of diarrhoea rather than systemic treatment of infection.
Pharmacokinetic properties include limited systemic exposure after normal dosing. Metabolism mainly occurs in the liver, with elimination through the urine and, to a lesser extent, the faeces. Patients with liver impairment or those taking certain other medicines may require professional assessment before use.
Because arret targets the gut specifically, improvements in stool consistency and reduced urgency can be expected after administration as directed. If there is no meaningful improvement after a short course, or if diarrhoea worsens, medical guidance should be sought. The leaflet accompanying the product provides further details about mechanism and safety considerations.
Follow the directions on the product packaging or as advised by a pharmacist or doctor. Do not exceed the recommended number of doses within a 24‑hour period, and do not keep taking the medicine for longer than advised unless a healthcare professional has instructed otherwise. The tablets or capsules should be swallowed whole with a drink of water; do not crush or chew unless the label permits.
Arret may be taken with or without food. It is generally advised to take the lowest effective dose for the shortest possible period to control symptoms. If the diarrhoea persists beyond the course or recurs after finishing a course, professional advice should be sought before continuing therapy.
In case of a missed dose, take it as soon as remembered, provided there is still time to the next scheduled dose. If it is almost time for the next dose, skip the missed dose and resume the regular schedule. Do not double up to make up for a missed dose without guidance from a healthcare professional.
Adults and eligible children should maintain hydration and monitor signs of dehydration. If there are any signs of dehydration, shortness of breath, fainting, or severe abdominal pain, seek urgent medical advice. Always refer to the product’s official leaflet for precise instructions and age-appropriate dosing information.
Known allergy to loperamide or any excipients in the product is a contraindication. A reaction could include swelling, rash, or difficulty breathing, requiring medical attention. If an allergy is suspected, the product should not be used.
Arret should not be used in the presence of acute dysentery with high fever or when there is blood in the stools, as these may indicate a more serious infection. In such circumstances, treatment with arret could worsen the condition without medical supervision.
The medicine is not suitable for individuals with known intestinal obstruction or severe inflammatory conditions of the bowel. Use in these situations may be unsafe and could lead to complications. Patients with dehydration or severe electrolyte imbalance are advised against use until evaluated by a clinician.
Children and adolescents should use arret only if directed by a healthcare professional and only when the product packaging indicates suitability for the age group. If there is any doubt regarding eligibility, consult a pharmacist or physician. If the patient is pregnant or breastfeeding, physician guidance is recommended before use.
Constipation is a possible side effect; if severe constipation or obstipation occurs, a healthcare professional should be consulted. Ongoing constipation may indicate the need to stop therapy and seek medical advice. Do not force bowel movements through exertion or continued dosing without guidance.
In patients with inflammatory bowel disease or other serious gut conditions, arret should be used with caution. The medication may mask or worsen certain symptoms and should be used only under medical supervision in these contexts. Seek medical advice if abdominal pain, fever, or blood in stools occurs while taking arret.
Long QT syndrome, severe liver impairment, and other significant health issues may alter the safety profile of loperamide. A healthcare professional should assess liver function and overall risk before initiating therapy in such circumstances. Regular monitoring may be advised in some cases.
Older adults and individuals with compromised nutritional status should be monitored for adverse effects, including dehydration. The possibility of dizziness or drowsiness exists, which could affect the ability to perform tasks requiring alertness. Avoid driving or operating machinery if dizziness occurs. If in doubt, consult a clinician for personalised advice.
Common side effects can include constipation, abdominal discomfort, and nausea. Mild symptoms such as dry mouth or a feeling of fullness in the abdomen may also occur. Most side effects are manageable and resolve with dose adjustment or cessation of therapy.
Less common effects may include dizziness, lightheadedness, or fatigue. There is a potential for hypersensitivity reactions such as skin rashes or itching in rare cases. If swelling of the face or tongue, severe rash, or breathing difficulties occur, seek urgent medical help.
Persistent or worsening constipation, abdominal pain, vomiting, or signs of dehydration should prompt medical consultation. If any adverse reaction is suspected, report to a healthcare professional or pharmacist for assessment. The information leaflet provides a complete list of possible adverse effects.
Severe or unexpected reactions are uncommon but require prompt medical attention. Do not continue taking arret if a serious reaction is suspected. For safety, maintain regular contact with a healthcare professional when using this medicine long term or in the context of other medical conditions.
Information about potential interactions should be reviewed with a pharmacist or clinician before starting arret. Some medicines may alter the absorption, effect, or safety of loperamide, and vice versa. Provide a full list of current medications to the healthcare professional to enable a proper assessment.
Specific interactions may occur with medicines that affect liver enzymes or transport proteins involved in drug handling. Potential interactions can change the amount of loperamide in the body and may influence side effects or effectiveness. Discuss all prescription, over‑the‑counter, and herbal products with a healthcare professional before initiating treatment.
Concomitant use of other medicines that slow gut movement could increase constipation or lead to discomfort. In addition, medicines that treat diarrhoea symptoms or dehydration might interact with loperamide’s mechanism. If unsure about a product, check the official leaflet or consult a pharmacist for guidance.
Alcohol consumption and certain foods are not known to have a direct dangerous interaction with arret, but dehydration can worsen symptoms. Hydration is essential; discuss any concerns about diet, supplements, or alcohol use with a clinician. When starting arret, it is prudent to review all concurrent therapies with a healthcare professional.
Pregnancy should be discussed with a healthcare professional before using arret. The potential benefits and risks must be weighed carefully, and the medication should only be used if clearly needed and advised by a clinician. If pregnancy is suspected while on arret, seek medical guidance promptly.
Breastfeeding is a consideration, as loperamide can pass into breast milk in very small amounts. If breastfeeding is planned or ongoing, consult a healthcare professional to determine whether continuation is appropriate. In some cases, alternative approaches for symptom control during lactation may be recommended.
In all cases, decisions regarding use during pregnancy or breastfeeding should involve a clinician. The official patient information leaflet provides product-specific recommendations, and professional guidance should be sought if any concerns arise. Do not start or continue therapy without professional advice during these periods.
Relief is often felt after taking the first dose, with improvement varying between individuals. The onset of action depends on factors such as the severity of symptoms and the specific product formulation. If there is no meaningful improvement after a short course, seek advice from a pharmacist or doctor.
If a dose is missed, take it as soon as it is remembered unless it is almost time for the next dose. Do not double the next dose to make up for a missed one. If in doubt, contact a healthcare professional for personalised guidance.
No major interactions are commonly reported, but alcohol can contribute to dehydration, especially if diarrhoea is present. It is sensible to limit alcohol while experiencing symptoms and to seek professional advice if concerns arise.
This medicine is intended for short-term symptom control. If diarrhoea continues beyond the initial course or recurs after stopping, medical advice should be sought before continuing therapy. A clinician can assess the need for further investigation or alternative treatment.
Medication reviews should be performed with a pharmacist or clinician before combining arret with other medicines. Some drugs may interact with loperamide, affecting its effect or safety. Ensure that a healthcare professional is aware of all medicines being used, including non‑prescription products and herbal supplements.
Use in children is age‑dependent and must follow the product’s labeling. Some formulations are not suitable for young children. Parents or carers should consult a pharmacist or doctor to confirm eligibility and dosing for a child.
Medical advice should be sought if dehydration signs appear, if stools contain blood, fever is present, or if diarrhoea lasts beyond a short course. Seek urgent medical help if there are severe abdominal pain, fainting, or an allergic reaction such as swelling of the face or throat, or if breathing difficulties occur.
Arret can be used for travel‑related diarrhoea or symptom control in adults under appropriate supervision. Long-term use without medical evaluation is not advised. A healthcare professional can discuss appropriate strategies for ongoing or recurrent symptoms.
The official patient information leaflet supplied with arret contains dosing instructions, safety information, and contraindications. It should be read fully before starting treatment and kept for reference during therapy. If any section is unclear, consult a pharmacist for clarification.
Healthcare professionals such as pharmacists and general practitioners can provide personalised advice based on medical history and current medications. In addition, reputable health services and national guidance documents offer patient‑friendly information on diarrhoea management and the use of anti‑diarrhoeal medicines. Always discuss any concerns with a qualified professional before continuing treatment.
For individuals seeking further information, it is advisable to check with product packaging and patient information leaflets for arret. Seek guidance from a clinician if there is any uncertainty about indications, dosing, or suitability for a specific health status. The aim is to ensure safe, effective, and appropriate use in the context of individual health needs.
14–21 days. Free from £149.08 .
5–9 days. £22.36
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
